// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Natural history of the pancreatic remnant after resection of Ipmn: preliminary results from a multi-institutional international study

M. Del Chiaro - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Intraductal papillary mucinous neoplasm

N/A

The influence of clinical and patient-reported outcomes (Proms) on post-surgery satisfaction in cholecystectomy patients

K. McLean - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gallbladder cancer

N/A

An ex-vivo normothermic porcine pancreas physiological model and implications for islet cell transplant

R. Kumar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Intranasal glucagon

Liver function after stage 1 and MELD score prior to stage 2 are predictors of mortality after ALPPS. An analysis of 319 patients in the International ALPPS Registry

E. Schadde - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A new technique for high biliary injury and stricture: Extended hepaticojejunostomy by an anterior approach

J.P. Lodge - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Delayed referral increases morbidity in cases of bile duct injury after cholecystectomy

S. Martinez-Lopez - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An increased post-operative inflammatory response is associated with reduced survival following resection of colorectal liver metastases

H. Shaker - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Raman spectroscopy with multivariate analysi Characterization and classification of biomarkers of pancreatic cancer

A. Mitchell - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Use of Basiliximab as initial immunosuppression for liver transplantation is renal protective

D.A. Longbotham - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Basiliximab

The Management of Colorectal Cancer with Synchronous liver-limited Metastatic Disease: An Audit of Current Practice Against European Society of Medical Oncology (ESMO) Guidelines.

M. Baltatzis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Does a fibrin glue sealant decrease post-operative pancreatic fistulae after pancreaticoduodenectomy; A single centre comparative study in 100 consecutive patients undergoing Whipple's procedure by a single surgeon

S.R. Khan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Over 75 year olds undergoing right hemihepatectomy are at a higher risk of post hepatectomy liver failure

D.A. Longbotham - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Retrospective analysis of perioperative and long-term outcomes after pancreas-sparing duodenectomy for duodenal cancer

M. Pitchaimuthu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Duodenal cancer

N/A

Long term survival following resection of colorectal liver metastases – the truth regarding the influence of complications

A.B. Fajardo-Puerta - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Laparoscopic parenchymal-sparing resections for centrally located non-peripheral liver lesions, the diamond technique: technical aspects, clinical outcomes and oncological efficiency

F. Cipriani - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

The metabolic phenotype of pancreatic cancer and its link to cytosolic calcium homeostasis, intracellular ATP and cell survival

A. Chan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

3-bromopyruvate

Nonanatomical resection favours survival in patients with right lobe only colorectal liver metastases

A.L. Young - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Left trisectionectomy for hepatobiliary malignancy: evolution of surgical technique, long term results and current status

S. Farid - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The long-term outcome of anti-oxidant therapy for chronic pancreatitis

A.K. Siriwardena - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Hereditary pancreatitis

N/A

Negative predictive value of drain amylase concentration for development of pancreatic fistula after pancreaticoduodenectomy

P.J. Zelga - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved